Navigation Links
Equity concerns raised by congestion pricing can be addressed to make approach viable
Date:6/1/2009

Policymakers need to address equity concerns early when implementing congestion pricing to improve traffic flow, as each situation is unique and must be evaluated on a case-by-case basis, according to a study issued today by the RAND Corporation.

Transportation policymakers often look to congestion pricing -- charging drivers more to travel particular routes at peak travel times -- as a way to reduce traffic gridlock and raise money for transportation projects. However, because these policies impose a cost on something that previously was not priced, critics often suggest that it will harm lower-income drivers who will be forced to pay additional costs or be "priced off" the roads.

"There is no single answer to the question of whether congestion pricing is equitable," said Thomas Light, co-author of the study and an associate economist with RAND, a nonprofit research organization. "The answer depends on how equity is defined and measured. It also depends on how congestion pricing is implemented and the characteristics of the region where it is put into practice."

The study was supported by a grant from the Environmental Defense Fund, a national environmental group.

"The research shows that equity issues can and must be addressed early on when designing a congestion pricing project," said Kathryn Phillips, who directs transportation advocacy in California for the Environmental Defense Fund. "A well-designed congestion pricing project can deliver clean air and less gridlock to everyone."

The RAND study evaluated alternative ways of defining and measuring equity and how such approaches interact with alternative forms of pricing, as well as the context in which congestion pricing is imposed. Light and study co-author Liisa Ecola reviewed dozens of studies and found that often congestion pricing results in most lower-income people paying less in taxes to fund transportation, although some proportion of the group may pay more.
'/>"/>

Contact: Lisa Sodders
lsodders@rand.org
310-451-6913
RAND Corporation
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Markets of biodiversity and equity in trade: An illusion?
2. SyntheMed Completes $2.8 Million Equity Financing
3. Concerns about food safety to be spotlighted at U of Minnesota symposium
4. More than a million cancer survivors declining care due to cost concerns
5. Study shows increased education on nanotech, human enhancement increases public concerns
6. Human embryonic stem cells developed from 4-cell embryo; world first may lessen ethical concerns
7. New study raises concerns about proposed mitigation strategy for marine bycatch
8. New study links fate of personal care products to environmental pollution and human health concerns
9. Study finds concerns with biofuels
10. New study increases concerns about climate model reliability
11. Direct-to-consumer advertising for genetic tests concerns physicians and may mislead patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...he community-associated strain of the deadly super... most common antibioticsposes a far greater health...y into hospitals, according to a study in the Dece... The new threat is easily picked up in fitness cen...reased the overall burden of MRSA within hospitals...
(Date:11/23/2009)...e Wildlife Conservation Society says that western ...public of Congopart of the "mother lode" of more t...ing increasingly threatened by growing humans acti...ction of the swamp forests adjacent to the southwe... surveys confirmed that high densities of the grea...
(Date:11/23/2009)...A new study provides "incontrovertible evidence" t...and of Sumatra about 73,000 years ago deforested m...icenter, researchers report. , The volcano eject...he atmosphere, leaving a crater (now the world,s l...and 35 kilometers wide. Ash from the event has bee...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Wolves lose their predatory edge in mid life new U of Minnesota study shows 60083 1Wolves lose their predatory edge in mid life new U of Minnesota study shows 60083 2NSF grant supports Rutgers Camden program for science majors 10524 1NSF grant supports Rutgers Camden program for science majors 10524 2NSF grant supports Rutgers Camden program for science majors 10524 3Bowel Disease Treatment May Raise Skin Cancer Risk 60079 1Bowel Disease Treatment May Raise Skin Cancer Risk 60079 2
...flying" lemur of Malaysia is the champion of all g...y, glide more than the length of two football fiel... on a tree trunk. , Researchers in Singapore, the...a, Berkeley, are discovering how these animals mov...with accelerometers. These devices, which measure ...
...cterium that harvests far-red light by making a ra...d its genetic secrets, according to a team of rese...e. , The researchers, from Arizona State Univers...n the current online edition (Feb. 4) of the Proce...hey have sequenced the genome of the cyanobacteriu...
...he availability of new genome sequencing technolog...test an intriguing hypothesis about how agricultur...n of plant pathogens. , Boris Vinatzer, assistant...d science in the College of Agriculture and Life S...lty Early Career Development (CAREER) award from t...
Other Biology News:Accelerometer backpacks aid study of gliding behavior in the 'flying' lemur 2Accelerometer backpacks aid study of gliding behavior in the 'flying' lemur 3Researchers decode genetics of rare photosynthetic bacterium 2Researchers decode genetics of rare photosynthetic bacterium 3Tomato pathogen genome may offer clues about bacterial evolution at dawn of agriculture 2
(Date:11/24/2009)... MATEO, Calif., Nov. 24 ...cal company focused on developing and commercializ...ay that Anthony DiTonno, President and Chief Execu...Annual Piper Jaffray Health Care Conference, to be...tel in New York, New York. ,, Mr. DiTonno and ...
(Date:11/24/2009)...rimary efficacy endpoint has been met for patients...cancer, , QUEBEC CITY, Nov. 24 /PRNewswire-Fi...TSX: AEZ) (the "Company"), a global biopharmaceuti...ogy, today announced positive efficacy data from a... conjugate, AEZS-108 (formerly AN-152), in patient...
(Date:11/24/2009)...OD CITY, Calif., Nov. 24 ...nced that Randy Scott, Genomic Health,s Executive ...ffray Health Care Conference in New York City on T...To access the live and subsequently archived webca...ns section of Genomic Health,s website at http://...
(Date:11/24/2009)...TTLE, Nov. 24 Cell Thera...ent will present at the 21st Annual Piper Jaffray ...d December 1-2, 2009, at the New York Palace Hotel...at 11:00 a.m. Eastern Time in Holmes 1 (4th Floor)...be available at www.celltherapeutics.com , and it...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
..., Feb. 5 Transcept,Pharmaceuticals, Inc. announce...ief Executive Officer, is scheduled to present at ...in New York City on Monday, February 9, 2009 at 9:...presentation will be available at, http://www.tran...be available,for 30 days. , About Transcept Ph...
...In a video interview Andrew,Witty, GlaxoSmithKline... as,"robust" in a year that was "always going to b...ill cease providing EPS guidance, to allow a,focus...2008 as a strategic turning point for GSK Mr Witty...d take to really make this company,strong over the...
...icromet, Inc. (Nasdaq: MITI ), today announced t...l present at the BIO CEO and Investor Conference a... February 10, 2009. A simultaneous webcast of the ...bsite at www.micromet-inc.com . , , , Forum: ... February 10, 2009, Time: 2:15 pm, Eastern ...
Other Biology Technology:Transcept Pharmaceuticals to Present at 11th Annual BIO CEO & Investor Conference 2Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009 2Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009 3Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009 4
Canine IL-10 ELISA Kit from R&D Systems
Rat Anti-Rat RT1Au (Class I Polymorphic) Monoclonal Antibody, Unconjugated from AbD Serotec
Mouse Anti-Human VEGF R Monoclonal Antibody, Phycoerythrin Conjugated, Clone 89106, 49560, 54733 from R&D Systems
Mouse Anti-Simian Virus 5 Monoclonal Antibody, FITC Conjugated from AbD Serotec
Biology Products: